Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/10/2025

Chlamydia Treatment Guidelines

First-Line Treatment Options

  • The American College of Physicians recommends treating uncomplicated chlamydia in adults with either azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days, both achieving 97-98% cure rates and being equally effective first-line options 1, 2
  • Azithromycin 1 g orally, single dose, is preferred when compliance is uncertain, as it allows directly observed therapy and eliminates adherence concerns 1, 2
  • Doxycycline 100 mg orally twice daily for 7 days is equally effective with lower cost and extensive clinical experience 1, 2

Alternative Treatment Regimens

  • Erythromycin base 500 mg orally four times daily for 7 days can be used as an alternative treatment regimen 1, 2
  • Levofloxacin 500 mg orally once daily for 7 days is an alternative treatment option, but it offers no compliance advantage over doxycycline and has inferior evidence 1, 2

Treatment During Pregnancy

  • The American College of Obstetricians and Gynecologists recommends azithromycin 1 g orally, single dose, as the preferred treatment for chlamydia during pregnancy 1, 2
  • Amoxicillin 500 mg orally three times daily for 7 days is an acceptable alternative treatment for chlamydia during pregnancy 1, 2, 3

Implementation Best Practices

  • The Centers for Disease Control and Prevention recommend dispensing medication on-site when possible and directly observing the first dose to maximize compliance 1, 2
  • Patients must abstain from all sexual intercourse for 7 days after initiating treatment and until all sex partners are treated 1, 2, 3

Follow-Up and Reinfection Screening

  • The American College of Physicians recommends that test-of-cure is NOT recommended for non-pregnant patients treated with recommended regimens who are asymptomatic, as cure rates exceed 97% 1, 2
  • Mandatory reinfection screening at 3 months is recommended for all women with chlamydia, as reinfection rates reach 39% in some populations and carry elevated risk for pelvic inflammatory disease 1, 2, 3

Coinfection Considerations

  • The Centers for Disease Control and Prevention recommend treating for both chlamydia and gonorrhea concurrently with ceftriaxone 250 mg IM single dose plus azithromycin 1 g orally single dose, as coinfection rates are 20-40% 1, 3
  • All chlamydia patients should be tested for gonorrhea, syphilis, and HIV at the initial visit 1

REFERENCES

1

Chlamydia Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

2

Chlamydia Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Chlamydia and Gonorrhea Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025